FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010912810> ?p ?o ?g. }

• W2010912810 endingPage "30" @default.
• W2010912810 startingPage "30" @default.
• W2010912810 abstract "BACKGROUND: Reduction of proteinuria is associated with delayed progression of chronic kidney disease. Reports suggest that angiotensin-receptor blockers (ARBs) reduce proteinuria, but results are variable. The relative effect of ARBs and angiotensin-converting enzyme (ACE) inhibitors, and their combined administration, remains uncertain. PURPOSE: To establish the effect of ARBs versus placebo and alternative treatments, and the effect of combined treatment with ARBs and ACE inhibitors, on proteinuria. DATA SOURCES: English-language studies in MEDLINE and the Cochrane Library Central Register of Controlled Trials (January 1990 to September 2006), reference lists, and expert contacts. STUDY SELECTION: Randomized trials of ARBs versus placebo, ACE inhibitors, calcium-channel blockers, or the combination of ARBs and ACE inhibitors in patients with or without diabetes and with microalbuminuria or proteinuria for whom data were available on urinary protein excretion at baseline and at 1 to 12 months. DATA EXTRACTION: Two investigators independently searched and abstracted studies. DATA SYNTHESIS: Forty-nine studies involving 6181 participants reported results of 72 comparisons with 1 to 4 months of follow-up and 38 comparisons with 5 to 12 months of follow-up. The ARBs reduced proteinuria compared with placebo or calcium-channel blockers over 1 to 4 months (ratio of means, 0.57 [95% CI, 0.47 to 0.68] and 0.69 [CI, 0.62 to 0.77], respectively) and 5 to 12 months (ratio of means, 0.66 [CI, 0.63 to 0.69] and 0.62 [CI, 0.55 to 0.70], respectively). The ARBs and ACE inhibitors reduced proteinuria to a similar degree. The combination of ARBs and ACE inhibitors further reduced proteinuria more than either agent alone: The ratio of means for combination therapy versus ARBs was 0.76 (CI, 0.68 to 0.85) over 1 to 4 months and 0.75 (CI, 0.61 to 0.92) over 5 to 12 months; for combination therapy versus ACE inhibitors, the ratio of means was 0.78 (CI, 0.72 to 0.84) over 1 to 4 months and 0.82 (CI, 0.67 to 1.01) over 5 to 12 months. The antiproteinuric effect was consistent across subgroups. LIMITATIONS: Most studies were small, varied in quality, and did not provide reliable data on adverse drug reactions. Proteinuria reduction is only a surrogate for important progression of renal failure. CONCLUSION: The ARBs reduce proteinuria, independent of the degree of proteinuria and of underlying disease. The magnitude of effect is similar regardless of whether the comparator is placebo or calcium-channel blocker. Reduction in proteinuria from ARBs and ACE inhibitors is similar, but their combination is more effective than either drug alone. Uncertainty concerning adverse effects and outcomes that are important to patients limits applicability of findings to clinical practice." @default.
• W2010912810 created "2016-06-24" @default.
• W2010912810 creator A5031705923 @default.
• W2010912810 creator A5043842967 @default.
• W2010912810 creator A5058128340 @default.
• W2010912810 creator A5062300664 @default.
• W2010912810 date "2008-01-01" @default.
• W2010912810 modified "2023-10-17" @default.
• W2010912810 title "Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease" @default.
• W2010912810 cites W1537972189 @default.
• W2010912810 cites W1595184853 @default.
• W2010912810 cites W165166058 @default.
• W2010912810 cites W1824408038 @default.
• W2010912810 cites W1980236207 @default.
• W2010912810 cites W1984061204 @default.
• W2010912810 cites W1998038903 @default.
• W2010912810 cites W2000034135 @default.
• W2010912810 cites W2000442546 @default.
• W2010912810 cites W2002616791 @default.
• W2010912810 cites W2016869426 @default.
• W2010912810 cites W2017268330 @default.
• W2010912810 cites W2019019126 @default.
• W2010912810 cites W2019261501 @default.
• W2010912810 cites W2019639026 @default.
• W2010912810 cites W2022846000 @default.
• W2010912810 cites W2023893179 @default.
• W2010912810 cites W2024635091 @default.
• W2010912810 cites W2027550108 @default.
• W2010912810 cites W2028330435 @default.
• W2010912810 cites W2044454891 @default.
• W2010912810 cites W2044773944 @default.
• W2010912810 cites W2045790461 @default.
• W2010912810 cites W2056976690 @default.
• W2010912810 cites W2061173243 @default.
• W2010912810 cites W2065267852 @default.
• W2010912810 cites W2070889309 @default.
• W2010912810 cites W2075429282 @default.
• W2010912810 cites W2077080091 @default.
• W2010912810 cites W2079178473 @default.
• W2010912810 cites W2083008696 @default.
• W2010912810 cites W2084343172 @default.
• W2010912810 cites W2094005904 @default.
• W2010912810 cites W2096213732 @default.
• W2010912810 cites W2097047271 @default.
• W2010912810 cites W2097288698 @default.
• W2010912810 cites W2098154750 @default.
• W2010912810 cites W2100923541 @default.
• W2010912810 cites W2104158979 @default.
• W2010912810 cites W2110754607 @default.
• W2010912810 cites W2111332484 @default.
• W2010912810 cites W2111945961 @default.
• W2010912810 cites W2112318790 @default.
• W2010912810 cites W2118094322 @default.
• W2010912810 cites W2118286022 @default.
• W2010912810 cites W2125435699 @default.
• W2010912810 cites W2125958513 @default.
• W2010912810 cites W2126930838 @default.
• W2010912810 cites W2128978422 @default.
• W2010912810 cites W2130235475 @default.
• W2010912810 cites W2135285685 @default.
• W2010912810 cites W2135856179 @default.
• W2010912810 cites W2140172772 @default.
• W2010912810 cites W2140745413 @default.
• W2010912810 cites W2141120643 @default.
• W2010912810 cites W2141128221 @default.
• W2010912810 cites W2142630332 @default.
• W2010912810 cites W2144042768 @default.
• W2010912810 cites W2148213697 @default.
• W2010912810 cites W2148303421 @default.
• W2010912810 cites W2152280966 @default.
• W2010912810 cites W2157382533 @default.
• W2010912810 cites W2159932069 @default.
• W2010912810 cites W2160541810 @default.
• W2010912810 cites W2170044433 @default.
• W2010912810 cites W2170453602 @default.
• W2010912810 cites W2170609859 @default.
• W2010912810 cites W2208579490 @default.
• W2010912810 cites W2261053353 @default.
• W2010912810 cites W2315123323 @default.
• W2010912810 cites W2323458614 @default.
• W2010912810 cites W2332330313 @default.
• W2010912810 cites W2487377689 @default.
• W2010912810 cites W2003670762 @default.
• W2010912810 cites W2296903449 @default.
• W2010912810 cites W3149800922 @default.
• W2010912810 doi "https://doi.org/10.7326/0003-4819-148-1-200801010-00190" @default.
• W2010912810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17984482" @default.
• W2010912810 hasPublicationYear "2008" @default.
• W2010912810 type Work @default.
• W2010912810 sameAs 2010912810 @default.
• W2010912810 citedByCount "665" @default.
• W2010912810 countsByYear W20109128102012 @default.
• W2010912810 countsByYear W20109128102013 @default.
• W2010912810 countsByYear W20109128102014 @default.
• W2010912810 countsByYear W20109128102015 @default.
• W2010912810 countsByYear W20109128102016 @default.
• W2010912810 countsByYear W20109128102017 @default.
• W2010912810 countsByYear W20109128102018 @default.

• next